CD19 Redirected Autologous T Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CD19 Redirected Autologous T Cells, covering 2017-02-07 to 2019-02-26. Get the full timeline:
Most recent: Clinical Trial Update: Dose Optimization Trial of CD19 Redirected Autologous T Cells [Phase 2]